Two Sigma Investments’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Two Sigma Investments’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-270,460	Closed	-$684K	–	3505
2023 Q4	$684K	Buy	+270,460	New	+$630K	﹤0.01%	2294
2023 Q2	–	Sell	-97,897	Closed	-$250K	–	3371
2023 Q1	$250K	Sell	97,897 -383,458	-80%	-$1.1M	﹤0.01%	2495
2022 Q4	$1.21M	Sell	481,355 -105,249	-18%	-$294K	﹤0.01%	1605
2022 Q3	$1.7M	Buy	586,604 +430,547	+276%	+$1.81M	0.01%	1222
2022 Q2	$705K	Buy	+156,057	New	+$928K	﹤0.01%	1687

Two Sigma Investments's SLGC Position: Q1 2024 in Review

Two Sigma Investments sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 270,460 shares — an estimated $684K sold.

Two Sigma Investments first reported a position in SLGC in Q2 2022 and held it in 5 quarters. The position peaked at $1.7M in Q3 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Two Sigma Investments reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Two Sigma Investments sold 270,460 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $684K.
Two Sigma Investments first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 5 quarters.
Two Sigma Investments's SomaLogic, Inc. Class A Common Stock position peaked at $1.7M in Q3 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.